Although the cell proliferation of H292 was not significantly affected when SGLT2 was absent (Supplemental Figure 6A), shRNA targeting SGLT2 (shSGLT2) significantly inhibited tumor volume compared with the control group (Vsh group) in the humanized NSG mouse model (Figure 6H). Here, SLC5A2 is linked to neoplasm.